These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15564232)

  • 41. Re: Efficacy and safety of the single pill combination of amlodipine 10 mg plus valsartan 160 mg in hypertensive patients not controlled by amlodipine 10 mg plus olmesartan 20 mg in free combination.
    Vivencio B
    Curr Med Res Opin; 2009 Sep; 25(9):2267-8; author reply 2268-9. PubMed ID: 19630488
    [No Abstract]   [Full Text] [Related]  

  • 42. [AT1 receptor antagonists in treatment of hypertension].
    Franz IW
    Fortschr Med; 1997 Jul; 115(19):38-40. PubMed ID: 9333581
    [No Abstract]   [Full Text] [Related]  

  • 43. Fetal toxic effects of angiotensin II receptor antagonists: case report and follow-up after birth.
    Bos-Thompson MA; Hillaire-Buys D; Muller F; Dechaud H; Mazurier E; Boulot P; Morin D
    Ann Pharmacother; 2005 Jan; 39(1):157-61. PubMed ID: 15590878
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety and efficacy of olmesartan: an observational pooled-analysis of 156,682 hypertensive patients.
    Scholze J; Schaefer A; Kreutz R
    Expert Opin Drug Saf; 2011 Mar; 10(2):185-96. PubMed ID: 21254872
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Valsartan inefficacy or ill-effects of concomitant medications!
    Bangalore S; Messerli FH
    Am J Cardiol; 2010 Aug; 106(4):602-3. PubMed ID: 20691326
    [No Abstract]   [Full Text] [Related]  

  • 47. Blood pressure management in acute stroke: does the Scandinavian Candesartan Acute Stroke Trial (SCAST) resolve all of the unanswered questions?
    Fischer U; Rothwell PM
    Stroke; 2011 Oct; 42(10):2995-8. PubMed ID: 21852619
    [No Abstract]   [Full Text] [Related]  

  • 48. Fetal toxic effects and angiotensin-II-receptor antagonists.
    Martinovic J; Benachi A; Laurent N; Daikha-Dahmane F; Gubler MC
    Lancet; 2001 Jul; 358(9277):241-2. PubMed ID: 11480433
    [No Abstract]   [Full Text] [Related]  

  • 49. The surge of Japanese studies supporting the use of angiotensin receptor blockers in hypertension.
    Kjeldsen SE; Narkiewicz K; Hedner T
    Blood Press; 2009; 18(5):240-1. PubMed ID: 19919393
    [No Abstract]   [Full Text] [Related]  

  • 50. Ask the doctor. I read that angiotensin-receptor blockers cause cancer. I take one (Diovan) for my blood pressure. Should I stop?
    Lee T
    Harv Heart Lett; 2010 Dec; 21(4):8. PubMed ID: 21218537
    [No Abstract]   [Full Text] [Related]  

  • 51. [Do angiotensin receptor blockers increased the risk of myocardial infarction? The landscape after ONTARGET study].
    Grajek S
    Kardiol Pol; 2008 Dec; 66(12):1313-24. PubMed ID: 19169980
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of the angiotensin-1 receptor blocker valsartan compared with amlodipine on renal hemodynamics.
    Epstein M; Hollenberg NK
    Am J Hypertens; 2004 Jul; 17(7):638-9; author reply 639-40. PubMed ID: 15233985
    [No Abstract]   [Full Text] [Related]  

  • 53. Angiotensin-II-receptor inhibitors in pregnancy.
    Chung NA; Lip GY; Beevers M; Beevers DG
    Lancet; 2001 May; 357(9268):1620-1. PubMed ID: 11386316
    [No Abstract]   [Full Text] [Related]  

  • 54. Efficacy and tolerability of candesartan cilexetil/hydrochlorothiazide and amlodipine in patients with poorly controlled mild-to-moderate essential hypertension.
    Fogari R; Mugellini A; Derosa G;
    J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):139-44. PubMed ID: 17907102
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Valsartan. Just a second-line antihypertensive drug.
    Can Fam Physician; 1999 Nov; 45():2626-8, 2630-3. PubMed ID: 10587770
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identifying patterns of adverse event reporting for four members of the angiotensin II receptor blockers class of drugs: revisiting the Weber effect.
    McAdams MA; Governale LA; Swartz L; Hammad TA; Dal Pan GJ
    Pharmacoepidemiol Drug Saf; 2008 Sep; 17(9):882-9. PubMed ID: 18636418
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A case of valsartan-induced pneumonitis with marked elevation of serum KL-6].
    Takakura A; Kubota M; Otani S; Katono K; Yamamoto M; Masuda N
    Nihon Kokyuki Gakkai Zasshi; 2011 Jul; 49(7):523-7. PubMed ID: 21842690
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Different potencies of angiotensin receptor blockers at suppressing adrenal β-Arrestin1-dependent post-myocardial infarction hyperaldosteronism.
    Lymperopoulos A; Sturchler E; Bathgate-Siryk A; Dabul S; Garcia D; Walklett K; Rengo G; McDonald P; Koch WJ
    J Am Coll Cardiol; 2014 Dec; 64(25):2805-6. PubMed ID: 25541135
    [No Abstract]   [Full Text] [Related]  

  • 59. [Telmisartan and valsartan].
    Perspect Infirm; 2013; 10(5):63. PubMed ID: 24358681
    [No Abstract]   [Full Text] [Related]  

  • 60. More about the "ARB MI paradox".
    Hall AS; Strauss MH
    Heart; 2007 Sep; 93(9):1011-4. PubMed ID: 17699164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.